电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

DDX58 抗体 (AA 203-925)

The 兔 多克隆 anti-DDX58 antibody (ABIN7872088) specifically detects DDX58 in WB, ELISA, IHC 和 FACS. The antibody is reactive with 人 samples.
产品编号 ABIN7872088
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for DDX58 抗体 (AA 203-925) (ABIN7872088)

抗原

See all DDX58 抗体
DDX58 (DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 58 (DDX58))

适用

  • 88
  • 42
  • 18
  • 2
  • 1

宿主

  • 82
  • 9
  • 1

克隆类型

  • 72
  • 20
多克隆

标记

  • 44
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
This DDX58 antibody is un-conjugated

应用范围

  • 78
  • 23
  • 19
  • 17
  • 14
  • 14
  • 11
  • 7
  • 5
  • 4
  • 4
  • 3
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS)
  • 抗原表位

    • 15
    • 5
    • 5
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 203-925

    原理

    RIGI Antibody / DDX58

    纯化方法

    Immunogen affinity purified

    免疫原

    E.coli-derived human DDX58/RIG-1 recombinant protein (Position: K203-K925) was used as the immunogen for the RIGI antibody.

    亚型

    IgG
  • 应用备注

    Optimal dilution of the RIGI antibody should be determined by the researcher.

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

    缓冲液

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

    储存条件

    4 °C,-20 °C

    储存方法

    After reconstitution, the RIGI antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
  • 抗原

    DDX58 (DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 58 (DDX58))

    别名

    RIGI

    背景

    RIGI antibody detects Retinoic acid-inducible gene I protein, encoded by the DDX58 gene on chromosome 9p21. RIGI antibody is widely applied in studies of innate immunity, antiviral defense, and RNA sensing pathways. RIG-I is a cytoplasmic pattern recognition receptor (PRR) belonging to the RIG-I-like receptor (RLR) family, which also includes MDA5 and LGP2. RIG-I detects viral double-stranded RNA with 5'-triphosphate ends and initiates signaling cascades that activate interferon production and antiviral gene expression. Expression is inducible by interferons and viral infection, and is present in a wide range of cell types, especially immune cells and epithelial cells.

    Structurally, RIG-I contains two N-terminal caspase activation and recruitment domains (CARDs), a central DExD/H-box helicase domain, and a C-terminal regulatory domain that binds RNA. The CARD domains recruit downstream adaptors, while the helicase and regulatory domains bind viral RNA. Conformational changes upon RNA binding expose the CARDs, enabling signaling activation. Post-translational modifications such as ubiquitination regulate RIG-I activation and turnover.

    Functionally, RIG-I is a critical sensor of viral RNA. Upon binding RNA ligands, it interacts with the mitochondrial antiviral signaling protein (MAVS), initiating signaling through TBK1, IKK epsilon, and IRF3/7, leading to type I interferon production. This antiviral program restricts replication of RNA viruses including influenza, vesicular stomatitis virus, and hepatitis C virus. RIG-I also influences adaptive immunity by modulating dendritic cell maturation and antigen presentation. Researchers employ RIGI antibody to study innate immune sensing, interferon biology, and antiviral responses.

    Clinically, RIG-I is associated with autoimmune disorders, infectious disease, and cancer. Gain-of-function mutations in DDX58 cause Singleton-Merten syndrome, an autoinflammatory disease with vascular calcification and lupus-like features. Aberrant RIG-I signaling contributes to chronic inflammation and autoimmunity, while defective responses increase susceptibility to viral infections. RIG-I also acts as a tumor suppressor by promoting cell death and interferon responses, but tumors may evade RIG-I signaling. NSJ Bioreagents offers RIGI antibody to support immunology, virology, and oncology research.

    Experimentally, RIGI antibody is used in western blotting to detect the ~102 kDa protein, in immunofluorescence to study cytoplasmic localization, and in immunohistochemistry to evaluate expression in infected or immune tissues. Co-immunoprecipitation with RIGI antibody identifies MAVS and signaling partners, enabling dissection of antiviral pathways.

    UniProt

    O95786

    途径

    Activation of Innate immune Response, Hepatitis C
You are here: